MARÍA DE MONTSERRAT FEIJÓO LÓPEZEDUARDO AGÜERA MORALESEVELIO FRANCISCO LUQUE CARABOT2026-01-292026-01-29201410.1016/j.ejphar.2014.02.0202-s2.0-84895778126https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/25233PharmacologyElevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stressresearch article